These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11682997)

  • 1. Consensus statement on long-term effectiveness research.
    Women Alive; 2000; ():9. PubMed ID: 11682997
    [No Abstract]   [Full Text] [Related]  

  • 2. I will urge caution.
    Garcia B
    WORLD; 2000 Jan; (105):5. PubMed ID: 11851144
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral rounds. CD4 count 423, viral load 12,000: time to treat anyway?
    Hodder S; Frank I
    AIDS Clin Care; 2006 Jun; 18(6):59-60. PubMed ID: 16791955
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term safety study of vicriviroc presented.
    Proj Inf Perspect; 2008 Dec; (47):13. PubMed ID: 19227564
    [No Abstract]   [Full Text] [Related]  

  • 5. [A chronic infection with long-term treatment].
    Grivois JP; Bricaire F
    Soins; 2004; (687):36-9. PubMed ID: 15384773
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-HIV agents. How long will a first regimen last?
    TreatmentUpdate; 2003; 15(5):1-2. PubMed ID: 17219614
    [No Abstract]   [Full Text] [Related]  

  • 7. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
    Mascolini M; Wensing AM; Boucher CA
    IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretroviral suppression of HIV in the context of persistently low CD4 counts: new insights.
    Laurence J
    AIDS Read; 2007 Jan; 17(1):7, 18. PubMed ID: 17274141
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-HIV agents. A warning about high viral loads.
    TreatmentUpdate; 2003; 15(7):1-2. PubMed ID: 17216865
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-HIV agents. Rescue therapy.
    TreatmentUpdate; 2000 Mar; 12(2):5-6. PubMed ID: 12125620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV agents. Can valproic acid help flush HIV from hiding?
    TreatmentUpdate; 2005; 17(6):4-5. PubMed ID: 17228475
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-HIV agents. Drug holidays.
    TreatmentUpdate; 2003; 15(5):3-4. PubMed ID: 17216856
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-HIV agents. Alternating regimens look promising.
    TreatmentUpdate; 2003; 15(5):2-3. PubMed ID: 17216855
    [No Abstract]   [Full Text] [Related]  

  • 15. The current status of antiretroviral therapy in Africa.
    Bray DH
    J HIV Ther; 2006 Mar; 11(1):7-10. PubMed ID: 16706249
    [No Abstract]   [Full Text] [Related]  

  • 16. New developments in STIs and SIT.
    Proj Inf Perspect; 2000 Oct; (31):5. PubMed ID: 12171020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatment guidelines.
    Vázquez E
    Posit Aware; 2002; 13(5):20. PubMed ID: 12400485
    [No Abstract]   [Full Text] [Related]  

  • 18. Enrollment halted in the SMART study.
    AIDS Clin Care; 2006 Feb; 18(2):15. PubMed ID: 16555391
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug news.
    Huff B
    GMHC Treat Issues; 2004; 18(9-10):13-5. PubMed ID: 15619787
    [No Abstract]   [Full Text] [Related]  

  • 20. Focus on hepatitis. HIV/HCV coinfection and ART.
    Carter M
    IAPAC Mon; 2006 May; 12(5):157. PubMed ID: 17249142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.